Expertise in
3
conditions

Dr. John A. Arrington

Radiology | Neuroradiology
Moffitt Magnolia Campus
12902 Usf Magnolia Dr, 
Tampa, FL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Referral may be required
Before you request
Expertise in
3
conditions
Moffitt Magnolia Campus
12902 Usf Magnolia Dr, 
Tampa, FL 

Overview

John Arrington is a Radiologist and a Neuroradiologist practicing medicine in Tampa, Florida.

Dr. Arrington is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pediatric Low-Grade Glioma (pLGG), Meningioma, Radiation Induced Meningioma, Caffey Disease, and Vertebroplasty.

He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 7 clinical trials. Dr. Arrington is currently accepting new patients.

Graduate Institution

University Of South Florida College Of Medicine

Specialties

Radiology
Neuroradiology

Licenses

Radiology in FL

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO

Locations

Moffitt Magnolia Campus
12902 Usf Magnolia Dr, Tampa, FL 33612

Additional Areas of Focus

Dr. Arrington has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer
Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer
Enrollment Status: Recruiting
Publish Date: May 18, 2026
Intervention Type: Diagnostic test
Study Phase: Phase 2
Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases
Phase I/II Study of Stereotactic Radiation and Abemaciclib in the Management of Hormone Receptor Positive HER2 Negative Breast Cancer Brain Metastases
Enrollment Status: Recruiting
Publish Date: February 06, 2026
Intervention Type: Radiation, Drug
Study Drugs: Abemaciclib, Endocrine Therapy
Study Phase: Phase 1/Phase 2
Phase Ib Study of Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
Phase Ib Study of Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Radiation, Drug
Study Drug: Nivolumab
Study Phase: Phase 1
A Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
A Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Radiation, Drug
Study Drugs: Pembrolizumab, Bevacizumab
Study Phase: Phase 1
Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) Combined With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) Combined With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: January 19, 2023
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, Bevacizumab, Ipilimumab
Study Phase: Phase 1
A Phase 1 Study of TPI 287 Concurrent With Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases From Advanced Breast and Non-Small Cell Lung (NSCL) Cancer
A Phase 1 Study of TPI 287 Concurrent With Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases From Advanced Breast and Non-Small Cell Lung (NSCL) Cancer
Enrollment Status: Terminated
Publish Date: February 04, 2021
Intervention Type: Drug, Procedure
Study Phase: Phase 1
Pilot Clinical Trial of COGNUTRIN in Breast Cancer Survivors
Pilot Clinical Trial of COGNUTRIN in Breast Cancer Survivors
Enrollment Status: Completed
Publish Date: July 14, 2020
Intervention Type: Other, Drug
Study Phase: Early Phase 1
View 5 Less Clinical Trials

29 Total Publications

Phase IB study of Avelumab and whole brain radiotherapy in patients with leptomeningeal disease from solid tumors: Results and molecular analyses.
Phase IB study of Avelumab and whole brain radiotherapy in patients with leptomeningeal disease from solid tumors: Results and molecular analyses.
Journal: Neuro-oncology
Published: September 01, 2025
Similar Doctors
Expertise in
57
conditions
Expertise in
57
conditions
Referral may be required
Before you request

Moffitt Magnolia Campus

12902 Usf Magnolia Dr, 
Tampa, FL 
 (0.1 miles away)
888-663-3488
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jamie Caracciolo is a Radiologist practicing medicine in Tampa, Florida. Dr. Caracciolo is highly rated in 57 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Epithelioid Sarcoma, Fibrosarcoma, Myxoid Liposarcoma, and Orchiectomy. Dr. Caracciolo is currently accepting new patients.

Expertise in
38
conditions
Dr. Les R. Folio
Radiology | Neuroradiology | Pediatric Radiology
Expertise in
38
conditions
Dr. Les R. Folio
Radiology | Neuroradiology | Pediatric Radiology
Referral may be required
Before you request

Moffitt Cancer Center, Magnolia Campus

12902 Usf Magnolia Dr, 
Tampa, FL 
 (0.1 miles away)
888-663-3488
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Les Folio is a Radiologist and a Neuroradiologist practicing medicine in Tampa, Florida. Dr. Folio is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Lymphofollicular Hyperplasia, Febrile Neutropenia, Bronchiectasis, and Pleurisy. Dr. Folio is currently accepting new patients.

Expertise in
49
conditions
Expertise in
49
conditions
Referral may be required
Before you request

Moffitt Magnolia Campus

12902 Usf Magnolia Dr, 
Tampa, FL 
 (0.1 miles away)
888-663-3488
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

David Carroll is a Radiologist practicing medicine in Tampa, Florida. Dr. Carroll is highly rated in 49 conditions, according to our data. His clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), Febrile Neutropenia, Colonic Malakoplakia, and Bone Marrow Aspiration. Dr. Carroll is currently accepting new patients.

Frequently Asked Questions about Dr. John A. Arrington

How do I make an appointment with Dr. John A. Arrington?

You can book an appointment with Dr. John A. Arrington by calling their office at 888-663-3488. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John A. Arrington a top-rated expert for Pediatric Low-Grade Glioma (pLGG)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John A. Arrington is classified as an Distinguished expert for Pediatric Low-Grade Glioma (pLGG), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John A. Arrington specialize in?

While Dr. John A. Arrington is a Radiology, they have specific expertise in Pediatric Low-Grade Glioma (pLGG), Meningioma, and Radiation Induced Meningioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiology.

Does Dr. John A. Arrington participate in research or clinical trials?

Yes. Dr. John A. Arrington has published 29 articles and abstracts on conditions like Pediatric Low-Grade Glioma (pLGG). You can view a list of Dr. John A. Arrington's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John A. Arrington accept my insurance?

Dr. John A. Arrington accepts most major insurance plans, including Aetna. We recommend calling the office directly at 888-663-3488 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Arrington's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile